A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer’s Disease Diagnosis Using Targeted Proteomics and Machine Learning

As disease-modifying therapies are now available for Alzheimer’s disease (AD), accessible, accurate and affordable biomarkers to support diagnosis are urgently needed. We sought to develop a mass spectrometry-based urine test as a high-throughput screening tool for diagnosing AD. We collected urine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hällqvist, Jenny, Pinto, Rui C., Heywood, Wendy E., Cordey, Jonjo, Foulkes, Alexander J. M., Slattery, Catherine F., Leckey, Claire A., Murphy, Eimear C., Zetterberg, Henrik, Schott, Jonathan M., Mills, Kevin, Paterson, Ross W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531486/
https://www.ncbi.nlm.nih.gov/pubmed/37762058
http://dx.doi.org/10.3390/ijms241813758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531486/
https://www.ncbi.nlm.nih.gov/pubmed/37762058
http://dx.doi.org/10.3390/ijms241813758

Ejemplares similares